AB
MGNX icon

Amalgamated Bank’s MacroGenics MGNX Stock Holding History

Amalgamated Bank’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,067
Closed -$3K – 3087
2025
Q1 		$3K Hold
2,067
– – ﹤0.01% 2793
2024
Q4 		$7K Hold
2,067
– – ﹤0.01% 2604
2024
Q3 		$7K Hold
2,067
– – ﹤0.01% 2626
2024
Q2 		$9K Hold
2,067
– – ﹤0.01% 2518
2024
Q1 		$30K Sell
2,067
-4,251
-67% -$64.3K ﹤0.01% 2004
2023
Q4 		$61K Sell
6,318
-615
-9% -$4.25K ﹤0.01% 2160
2023
Q3 		$32K Hold
6,933
– – ﹤0.01% 2444
2023
Q2 		$37K Buy
6,933
+729
+12% +$4.5K ﹤0.01% 2443
2023
Q1 		$44K Sell
6,204
-1,397
-18% -$8.41K ﹤0.01% 2353
2022
Q4 		$51K Hold
7,601
– – ﹤0.01% 2410
2022
Q3 		$26K Hold
7,601
– – ﹤0.01% 2733
2022
Q2 		$22K Sell
7,601
-1,972
-21% -$10.4K ﹤0.01% 2836
2022
Q1 		$84K Sell
9,573
-800
-8% -$8.83K ﹤0.01% 2264
2021
Q4 		$166K Sell
10,373
-104
-1% -$1.96K ﹤0.01% 1995
2021
Q3 		$219K Sell
10,477
-436
-4% -$10.5K ﹤0.01% 1958
2021
Q2 		$293K Buy
+10,913
New +$320K ﹤0.01% 1896

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Bank's MGNX Position: Q2 2025 in Review

Amalgamated Bank sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 2,067 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in MGNX in Q2 2021 and held it in 16 quarters. The position peaked at $293K in Q2 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Amalgamated Bank reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 2,067 MacroGenics shares in Q2 2025, an estimated $3K.
  • Amalgamated Bank first reported a position in MacroGenics in Q2 2021 and held it in 16 quarters.
  • Amalgamated Bank's MacroGenics position peaked at $293K in Q2 2021.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.